Case Study

Clinical Validation of Artificial Intelligence–Augmented Pathology Diagnosis Demonstrates Significant Gains in Diagnostic Accuracy in Prostate Cancer Detection

Paige designed this ground-breaking study to understand how assistance from Paige Prostate Detect, an AI that aids in the detection of prostate cancers, could impact pathologist performance.

The study’s outcomes were pivotal in Paige Prostate Detect ultimately receiving the first FDA-approval for an AI in pathology

The study found that:

  • Paige Prostate Detect reduced cancer detection errors by 70%
  • Statistically significant sensitivity gains were seen among non-GU pathologists and GU pathologists

Paige provides results you can rely on. 

Complete the form below to access this case study showcasing real-world use of Paige products.